SET Nuclear Oncogene (SET) (N-Term) Peptide
SET
宿主: 合成
BP, IHC, WB, IP
产品编号 ABIN8111551
发货至:
中国
Contact our Customer Service for availability and price in your country.
Contact Info
Our Local Distributor
中国
北京 101111
北京 101111
No. 88 KeChuang 6th Street
Beijing Economic Technological Development Area
Room 801-803
Quick Overview for SET Nuclear Oncogene (SET) (N-Term) Peptide (ABIN8111551)
抗原
SET/TAF-I (SET)
(SET Nuclear Oncogene (SET))
资源
合成
应用范围
Blocking Peptide (BP), Immunohistochemistry (IHC), Western Blotting (WB), Immunoprecipitation (IP)
-
-
蛋白结构域
- N-Term
-
原理
- SET Peptide - N-terminal region
-
-
-
-
应用备注
- Optimal working dilution should be determined by the investigator.
-
说明
-
This is a synthetic peptide designed for use in combination with anti-SET antibody ( ARP56542_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
限制
- 仅限研究用
-
-
-
状态
- Lyophilized
-
溶解方式
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
缓冲液
- Lyophilized powder
-
储存条件
- -20 °C
-
储存方法
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- SET/TAF-I (SET) (SET Nuclear Oncogene (SET))
-
背景
-
Background Information: SET is a multitasking protein, involved in apoptosis, transcription, nucleosome assembly and histone binding. Isoform 2 anti-apoptotic activity is mediated by inhibition of the GZMA-activated DNase, NME1. In the course of cytotoxic T-lymphocyte (CTL)-indu
Alternative Symbols: 2PP2A, I2PP2A, IGAAD, PHAPII, TAF-IBETA, TAF-I, IPP2A2
-
分子量
- 32kDa
-
基因ID
- 6418
-
NCBI登录号
- NP_003002
-
UniProt
- B2RCX0
抗原
-
You are here:
